RE:RE:when you have an infestestation...Tundup, thanks for your posts just some thoughts in response....
Interesting numbers that you brought up in your last post. I myself don't tend to trade much in positions I take but I do watch to some degree the trading patterns. Morgan Stanley today is net over 200,000 shares purchased (last I looked they had sold 400). I have been watching them for a while and since Dec/Jan they have now purchased over 600,000 shares and sold less than 1000 in the same period. Although I can not say whether it is one entity buying or numerous entities, the fact that the shares are purchased in tight groupings would lead me to think that the number is smaller than larger. If it is one entity buying then the market value today would be roughly $2.3 million, larger but in the neighbourhood you are talking about. My point is that there is in fact some opportunity for somewhat larger, focussed buying.
With respect to your first post I agree with most of it but I think that to RVX management share price is more of a secondary concern. I get the feeling from questions I've asked over the last while that they feel, rightly or wrongly, that they have financial backing in place to see this through ph3 and are not looking too hard at strategic options. Obviously a higher share price means you have to give up less to any source of funding but thus far Eastern has been very fair wrt to minority shareholders and again just my impression but I think that is the well management will continue to draw from. I also get the feeling that they have done alot of talking with pharma and have a very good idea of what they need to do with ph3 to satisfy that side of the equation.
To your point about being in a position to start striking deals, I agree if you are talking about regional licensing deals but I definitely think they have to be considering how any deals struck in the shorter term are going to fit into the likely out and out sale in the longer term.
As far as not being able to explain the MOA I think while that was very likely true in the past I think now they are more likely just being very tight with their IP. In the seeking Alpha article Norman Wong's response to BC's questions would indicate this. Further to this point both Eastern and NGN have significant scientific resources of their own as well as capital and as such would likely not be providing the continuous support that they have if they didn't feel the science was tight and getting tighter. I would say further financing will confirm this.